Allworth Financial’s FibroBiologics FBLG Stock Holding History

Allworth Financial’s Portfolio FBLG Stock Details FBLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13	Hold	13	–	–	﹤0.01%	5119
2026 Q1	$18	Hold	13	–	–	﹤0.01%	5139
2025 Q4	$59	Hold	13	–	–	﹤0.01%	4830
2025 Q3	$143	Hold	13	–	–	﹤0.01%	4640
2025 Q2	$163	Hold	13	–	–	﹤0.01%	4344
2025 Q1	$337	Hold	13	–	–	﹤0.01%	3774
2024 Q4	$441	Hold	13	–	–	﹤0.01%	3636
2024 Q3	$806	Hold	13	–	–	﹤0.01%	3296
2024 Q2	$1.17K	Hold	13	–	–	﹤0.01%	3113
2024 Q1	$2.82K	Buy	+13	New	+$3.13K	﹤0.01%	2675

Other funds holding FBLG

CFP

Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return

FEG

Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Allworth Financial's FBLG Position: Q2 2026 in Review

Allworth Financial held its FibroBiologics (FBLG) position steady in Q2 2026 at 13 shares worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #5119.

Allworth Financial first reported a position in FBLG in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.82K in Q1 2024. 16 funds tracked by Wall St. Rank hold FBLG as of Q2 2026.

Allworth Financial held 13 shares of FibroBiologics worth $13 as of Q2 2026.
Allworth Financial left its FibroBiologics share count unchanged in Q2 2026.
FibroBiologics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #5119 holding.
Allworth Financial first reported a position in FibroBiologics in Q1 2024 and has held it in 10 quarters since.
Allworth Financial's FibroBiologics position peaked at $2.82K in Q1 2024.
16 funds tracked by Wall St. Rank held FibroBiologics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.